Angiotensin II infusion increases thoracic duct lymph flow in chronically catheterized sheep.
Both pregnancy and estrogen administration are associated with a decrease in the systemic vasculature pressor response to angiotensin II infusion; however, the lymphatic vessel system response is not clear. In the present study we infused angiotensin II to nine nonpregnant splenectomized ewes with 0.1, 10, or 1,000 ng X kg-1 X min-1 for a 5-min period at each dose. At the lowest dose the mean arterial pressure increased from 10 to 20% over base line. At the highest dose, the left thoracic duct flow rate peaked at 361% 10 min after the infusion was started, whereas arterial pressure peaked at 183% of the control value. Peak lymph flow occurred 4-6 min after the maximal increase in mean systemic arterial pressure. Neither hematocrit nor venous pressure were altered at any of the doses administered. This suggests that the interstitial fluid space pressure remained unchanged and that the increase in lymph flow was not secondary to fluid transfer from the intravascular system. We postulate, therefore, that the effect of angiotensin II in the increase of lymph flow rate is by direct action on the lymphatic vessels themselves.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002404:Catheterization; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007262:Infusions, Intravenous; D008196:Lymph / Q000187:drug effects* / Q000502:physiology; D008488:Medical Illustration; D012756:Sheep; D013897:Thoracic Duct / Q000187:drug effects* / Q000502:physiology; D013997:Time Factors
D000804:Angiotensin II